Name: VISTIN PHARMA ASA (VISTN) Stock
Brand: VISTIN PHARMA ASA
Rating: 3 (3 reviews)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

Show Percentage Diff	TTM (2025-6-30)	2024 (2024-12-31)	2023 (2023-12-31)	2022 (2022-12-31)	2021 (2021-12-31)
Revenue	451.83M	429.09M	435.39M	287.68M	275.81M
Gross Premiums Earned	null	null	null	null	null
Loss Claims	null	null	null	null	null
Deferred Policy Acquisition Expense	null	null	null	null	null
Net Interest Income	null	null	null	null	null
Non Interest Income	null	null	null	null	null
Loan Loss Provision	null	null	null	null	null
Net Interest Income after Provision	null	null	null	null	null
Non Interest Expense	null	null	null	null	null
Minority Interest Expense	null	null	null	null	null
Cost Of Goods	151.91M	149.97M	176.64M	138.06M	96.10M
Gross Profit	299.93M	279.12M	258.75M	149.61M	179.72M
Operating Expenses	202.53M	193.83M	190.15M	155.71M	146.47M
Research and Development	null	null	null	null	null
Selling, General, and Administrative Expenses	98.16M	94.22M	93.14M	78.97M	73.43M
Operating Income	97.40M	85.30M	68.60M	-6.09M	33.25M
Interest Income/Expense	171.00K	-4.88M	-9.97M	400.00K	-1.22M
Other Income/Expense	null	37.00K	-112.00K	-313.00K	-35.00K
Non Recurring Items	null	null	null	null	null
Income Before Taxes	97.57M	80.45M	58.52M	-6.01M	32.00M
Income Tax	21.47M	17.70M	12.92M	-1.29M	7.13M
Net Income	76.10M	62.75M	45.60M	-4.72M	24.87M
EBITDA	117.04M	104.33M	85.94M	6.18M	43.86M

Per Share Data
EPS Diluted Total Ops	1.7162	1.415	1.0282	-0.1064	0.5608
Non GAAP EPS	null	null	null	null	null

Statistics
Gross Profit Margin	66.38%	65.05%	59.43%	52.01%	65.16%
Profit Margin	16.84%	14.62%	10.47%	-1.64%	9.02%
Operating Profit Margin	21.56%	19.88%	15.76%	-2.12%	12.06%

All data in NOK

VISTIN PHARMA ASA (VISTN.OL) Stock Income Statement

Charts